TY - JOUR
T1 - Mechanism of lithium-induced augmentation of T-cell proliferation
AU - Kucharz, Eugene J.
AU - Sierakowski, Stanislaw
AU - Staite, Nigel D.
AU - Goodwin, James S.
PY - 1988
Y1 - 1988
N2 - The mechanism whereby lithium augments mitogen-stimulated T-cell proliferation was investigated. Lithium in a concentration of 5mM caused a significant increase in interleukin 2 (IL-2) production after phytohemagglutinin (PHA) stimulation. Lithium also caused an increase in interleukin 1 production from peripheral blood monocytes. Lithium did not influence the expression of IL-2 receptors on T-cells. However, lithium did result in increased proliferative response to IL-2 in an IL-2 responsive cell line. Thus, lithium influences the T-cell proliferation response to mitogens in several ways, by stimulation of lymphokine and monokine production as well as by augmenting the response of IL-2 responsive cells to IL-2.
AB - The mechanism whereby lithium augments mitogen-stimulated T-cell proliferation was investigated. Lithium in a concentration of 5mM caused a significant increase in interleukin 2 (IL-2) production after phytohemagglutinin (PHA) stimulation. Lithium also caused an increase in interleukin 1 production from peripheral blood monocytes. Lithium did not influence the expression of IL-2 receptors on T-cells. However, lithium did result in increased proliferative response to IL-2 in an IL-2 responsive cell line. Thus, lithium influences the T-cell proliferation response to mitogens in several ways, by stimulation of lymphokine and monokine production as well as by augmenting the response of IL-2 responsive cells to IL-2.
UR - http://www.scopus.com/inward/record.url?scp=0023952286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023952286&partnerID=8YFLogxK
U2 - 10.1016/0192-0561(88)90056-2
DO - 10.1016/0192-0561(88)90056-2
M3 - Article
C2 - 3263331
AN - SCOPUS:0023952286
SN - 0192-0561
VL - 10
SP - 253
EP - 259
JO - International Journal of Immunopharmacology
JF - International Journal of Immunopharmacology
IS - 3
ER -